Feb 12, 2014
Avail is conducting a randomized, placebo-controlled study to assess the efficacy, long-term safety and tolerability of a new high cholesterol drug in subjects with primary hyperlipidemia or mixed dyslipidemia at risk of cardiovascular events.
Feb 11, 2014
Achieve is conducting a placebo-controlled study to evaluate the blood pressure reduction with ambulatory blood pressure monitoring (ABPM), safety, and tolerability of a new drug in the treatment of subjects with hypertension and type 2 diabetes.
Jan 25, 2014
Achieve is conducting a placebo-controlled study of the efficacy, tolerability and safety of a new high cholesterol drug in reducing the occurrence of major cardiovascular (CV) events in high risk subjects with high cholesterol.
Jan 22, 2014
Avail is conducting a randomized study to evaluate the safety and efficacy of a new hepatitis drug in combinations with simeprevir and/or ritonavir with or without Ribavirin for 12 weeks in participants with chronic hepatitis C infection.
Dec 11, 2013
Paid Arthritis Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting M/F Patients with Active Psoriatic Arthritis Age 18 - 75
Dec 10, 2013
Avail is conducting a randomized, vehicle-controlled study to evaluate the safety and efficacy of a advanced form of rectal suppositories in the treatment of adult subjects with symptomatic internal hemorrhoids.
Nov 20, 2013
Avail is conducting a randomized, multi-center study of the pharmacodynamics, pharmacokinetics, and tolerability of a new liquid form drug in adult patients with chronic idiopathic constipation.
Nov 19, 2013
Achieve is conducting a safety and efficacy study on a new combination asthma treatment versus an inhaled treatment for adolescents and adult patients with asthma.
Oct 31, 2013
While government health sites remain behind the times, Clinical Trials GPS provides patients with up to date trial and facility data, new patient dashboard and study promotion tools for research sites.
Oct 16, 2013
Achieve is conducting a randomized, single-dose study comparing the efficacy and safety of a combination of acetaminophen and aspirin vs placebo in the acute treatment of migraine headaches.